Accord Gets EMA Support For Arsenic Trioxide
Executive Summary
Positive opinions on Accord’s arsenic trioxide, Kabi’s bortezomib and Orphelia Pharma’s clofarabine were among the latest rafts of recommendations for approval made by the European Medicines Agency’s CHMP.